Jounce Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JNCE and other ETFs, options, and stocks.

About JNCE

Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which treats cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients. Its product pipeline includes JTX-2011 (ICOS), JTX-4014 (PD-1), the Lead Macrophage Program, Macrophage Targeting, T Reg, B Cells, and Stromal Targeting. 

CEO
Richard Murray
CEORichard Murray
Employees
137
Employees137
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2013
Founded2013
Employees
137
Employees137

JNCE Key Statistics

Market cap
130.79M
Market cap130.79M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
218.25K
Average volume218.25K
High today
$2.62
High today$2.62
Low today
$2.35
Low today$2.35
Open price
$2.35
Open price$2.35
Volume
367.05K
Volume367.05K
52 Week high
$9.81
52 Week high$9.81
52 Week low
$2.12
52 Week low$2.12

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
28.6%
Sell
0%

JNCE Earnings

-$0.72
-$0.48
-$0.24
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, Pre-Market
ActualExpected Nov 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.